Search Results 291-300 of 17360 for GLP-1 secretion
This study evaluates the combination of CBT-1® and doxorubicin for the treatment of metastatic, unresectable sarcoma in patients who have progressed after ...
The purpose of this study is to evaluate molecular markers which might be a predictor of pancreatic cancer or precancer by analyzing the secretions (fluid) from ...
An abnormality in the pituitary gland can impair the release of hormones from the pituitary gland to the testicles, affecting normal testosterone production. A ...
... 1 of 6 standard of care (SOC) chemotherapy regimens for the treatment of advanced colorectal carcinoma. The primary study hypothesis is that pembrolizumab ...
The purpose of this study to assess pharmacodynamic (PD) changes in tumor tissue. Participation eligibility. Participant eligibility includes age, gender, type ...
... 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market. Study IDs. Site IRB.
Mayo Clinic researchers have developed a genetic test that can help predict how people will respond to weight loss medications such as GLP-1s. Latest ...
Meditation. Yoga. Massage. Acupuncture. Use of supplements, such as vitamins, herbs and minerals. Music therapy. Integrative medicine aims to fit each person's ...
Sort by: Faculty · Areas of Research · active Find a program led by a researcher whose last name begins with the letter A A · Find a program led by a ...
Eligibility last updated 9/1/21. Questions regarding updates should be directed to the study team contact. Participating Mayo Clinic locations. Study ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.